Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Appropriate dosage of methimazole after radioactive iodine treatment
TCTR20230426008Phase 2Unknown
- Sponsor
- Siriraj Research Development Fund
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methimazole in thyroid disease, sponsored by Siriraj Research Development Fund. Status: unknown.
02
Drugs
methimazole
03
Conditions
thyroid disease
Beyond the preview
Go deeper on TCTR20230426008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230426008.